课题基金 / 基金详情

MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS

MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS
母体 DDAVP 用于治疗水少症
批准号：
6117100
负责人：
Michael Glenn Ross
金额：
$3.89万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6117100
关键词：
amniotic fluid arginine vasopressin body water body water dehydration clinical research hormone therapy human pregnant subject human therapy evaluation outcomes research pregnancy disorder pregnancy disorder chemotherapy urine

项目摘要

项目成果

Michael Glenn Ross的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Potential therapeutic utility of maternal dDAVP for patients with oligohydramnios (insufficient amniotic fluid). Despite the significant consequences of oligohydramnios, there are no established means to increase amniotic fluid volume prior to labor. Recent studies indicate the potential of a novel treatment for oligohydramnios, utilizing maternal administration of a drug (dDAVP) to hydrate mother&secondly baby with amniotic fluid. The baby hydrates in relation to mother&increases its urine production and thus amniotic fluid.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Programmed Gestational Hyperphagia
Mechanisms of Programmed Gestational Hyperphagia
Mechanisms of Programmed Gestational Hyperphagia
Mechanisms of Programmed Gestational Hyperphagia
海外基金